169 related articles for article (PubMed ID: 35347431)
21. Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: A nationwide population study.
Tai TW; Li CC; Huang CF; Chan WP; Wu CH
Bone; 2022 Jan; 154():116216. PubMed ID: 34571203
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density enhances use of clinical risk factors in predicting ten-year risk of osteoporotic fractures in Chinese men: the Hong Kong Osteoporosis Study.
Bow CH; Tsang SW; Loong CH; Soong CS; Yeung SC; Kung AW
Osteoporos Int; 2011 Nov; 22(11):2799-807. PubMed ID: 21234548
[TBL] [Abstract][Full Text] [Related]
23. Increased fracture risk in Parkinson's disease - An exploration of mechanisms and consequences for fracture prediction with FRAX.
Schini M; Bhatia P; Shreef H; Johansson H; Harvey NC; Lorentzon M; Kanis JA; Bandmann O; McCloskey EV
Bone; 2023 Mar; 168():116651. PubMed ID: 36574893
[TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease and risk of hip fracture: an 8-year follow-up study in Taiwan.
Chen YY; Cheng PY; Wu SL; Lai CH
Parkinsonism Relat Disord; 2012 Jun; 18(5):506-9. PubMed ID: 22297125
[TBL] [Abstract][Full Text] [Related]
25. The association of Parkinson's disease with bone mineral density and fracture in older women.
Schneider JL; Fink HA; Ewing SK; Ensrud KE; Cummings SR;
Osteoporos Int; 2008 Jul; 19(7):1093-7. PubMed ID: 18301855
[TBL] [Abstract][Full Text] [Related]
26. Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease.
Critchley RJ; Khan SK; Yarnall AJ; Parker MJ; Deehan DJ
Br Med Bull; 2015 Sep; 115(1):135-42. PubMed ID: 26130734
[TBL] [Abstract][Full Text] [Related]
27. Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
Ross BJ; Ross AJ; Lee OC; Waters TL; Familia MM; Sherman WF
Osteoporos Int; 2022 Sep; 33(9):1999-2010. PubMed ID: 35670832
[TBL] [Abstract][Full Text] [Related]
28. Fractures in type 2 diabetes confer excess mortality: The Dubbo osteoporosis epidemiology study.
Sheu A; Bliuc D; Tran T; White CP; Center JR
Bone; 2022 Jun; 159():116373. PubMed ID: 35231635
[TBL] [Abstract][Full Text] [Related]
29. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
Bone; 2023 Jan; 166():116605. PubMed ID: 36347433
[TBL] [Abstract][Full Text] [Related]
30. Impact of diabetes on the risk of subsequent fractures in 92,600 patients with an incident hip fracture: A Danish nationwide cohort study 2004-2018.
Vinther D; Thomsen RW; Furnes O; Gjertsen JE; Pedersen AB
Bone; 2024 Jul; 184():117104. PubMed ID: 38636621
[TBL] [Abstract][Full Text] [Related]
31. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
[TBL] [Abstract][Full Text] [Related]
32. Screening for women with increased risk of fragility fractures in a general female population using digital X-ray radiogrammetry (DXR).
Wilczek ML; Bhatta L; Brumpton BM; Freyschuss B; Brismar TB
Maturitas; 2021 Feb; 144():60-67. PubMed ID: 33358210
[TBL] [Abstract][Full Text] [Related]
33. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
[TBL] [Abstract][Full Text] [Related]
34. The risk of hip and non-vertebral fractures in patients with Parkinson's disease and parkinsonism: A systematic review and meta-analysis.
Schini M; Vilaca T; Poku E; Harnan S; Sutton A; Allen IE; Cummings SR; Eastell R
Bone; 2020 Mar; 132():115173. PubMed ID: 31790846
[TBL] [Abstract][Full Text] [Related]
35. Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010.
Klop C; Gibson-Smith D; Elders PJ; Welsing PM; Leufkens HG; Harvey NC; Bijlsma JW; van Staa TP; de Vries F
Osteoporos Int; 2015 Jul; 26(7):1919-28. PubMed ID: 25963232
[TBL] [Abstract][Full Text] [Related]
36. Greater risk of hip fracture in hemodialysis than in peritoneal dialysis.
Chen YJ; Kung PT; Wang YH; Huang CC; Hsu SC; Tsai WC; Hsu HC
Osteoporos Int; 2014 May; 25(5):1513-8. PubMed ID: 24557014
[TBL] [Abstract][Full Text] [Related]
37. Herpes zoster and the risks of osteoporosis and fracture: a nationwide cohort study.
Lin SM; Wang CY; Chen YY; Wang JH; Liang CC; Huang HK
Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):365-372. PubMed ID: 30460416
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk factors of subsequent osteoporotic fracture: a nationwide cohort study in South Korea.
Shim YB; Park JA; Nam JH; Hong SH; Kim JW; Jeong J; Shin JY
Arch Osteoporos; 2020 Nov; 15(1):180. PubMed ID: 33188505
[TBL] [Abstract][Full Text] [Related]
39. Fracture prevention by screening for high fracture risk: a systematic review and meta-analysis.
Merlijn T; Swart KMA; van der Horst HE; Netelenbos JC; Elders PJM
Osteoporos Int; 2020 Feb; 31(2):251-257. PubMed ID: 31838551
[TBL] [Abstract][Full Text] [Related]
40. Statin Use Is Associated With Decreased Osteoporosis and Fracture Risks in Stroke Patients.
Lin SM; Wang JH; Liang CC; Huang HK
J Clin Endocrinol Metab; 2018 Sep; 103(9):3439-3448. PubMed ID: 29982482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
